"Aged, 80 and over" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A person 80 years of age and older.
| Descriptor ID |
D000369
|
| MeSH Number(s) |
M01.060.116.100.080
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Aged, 80 and over".
Below are MeSH descriptors whose meaning is more specific than "Aged, 80 and over".
This graph shows the total number of publications written about "Aged, 80 and over" by people in this website by year, and whether "Aged, 80 and over" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 41 | 41 |
| 1997 | 0 | 46 | 46 |
| 1998 | 0 | 44 | 44 |
| 1999 | 0 | 55 | 55 |
| 2000 | 0 | 52 | 52 |
| 2001 | 1 | 57 | 58 |
| 2002 | 0 | 87 | 87 |
| 2003 | 0 | 111 | 111 |
| 2004 | 1 | 107 | 108 |
| 2005 | 0 | 125 | 125 |
| 2006 | 0 | 115 | 115 |
| 2007 | 0 | 134 | 134 |
| 2008 | 0 | 188 | 188 |
| 2009 | 0 | 171 | 171 |
| 2010 | 0 | 188 | 188 |
| 2011 | 0 | 230 | 230 |
| 2012 | 0 | 235 | 235 |
| 2013 | 0 | 277 | 277 |
| 2014 | 0 | 280 | 280 |
| 2015 | 1 | 297 | 298 |
| 2016 | 0 | 315 | 315 |
| 2017 | 0 | 288 | 288 |
| 2018 | 0 | 346 | 346 |
| 2019 | 0 | 331 | 331 |
| 2020 | 0 | 290 | 290 |
| 2021 | 0 | 225 | 225 |
| 2022 | 0 | 61 | 61 |
| 2023 | 0 | 67 | 67 |
| 2024 | 0 | 244 | 244 |
| 2025 | 0 | 252 | 252 |
| 2026 | 0 | 88 | 88 |
To return to the timeline,
click here.
Below are the most recent publications written about "Aged, 80 and over" by people in Profiles.
-
The Safety and Efficacy of Colorectal Endoscopic Submucosal Dissection in the Elderly: A Large Western Analysis of 710 Lesions. J Clin Gastroenterol. 2026 Sep 01; 60(8):715-721.
-
Symptom Tracking for Patient-Reported Outcomes in Cancer: User-Centered Design of the AthenaCompanion Web Application. J Med Internet Res. 2026 Aug 05; 28:e94017.
-
Safety, tolerability, and efficacy of flexible-dose tavapadon for Parkinson's disease (TEMPO-2): a phase 3, randomised, placebo-controlled, double-blind trial. Lancet Neurol. 2026 Aug; 25(8):721-730.
-
Health care use and costs associated with clinically impactful immune-related adverse events during immune checkpoint inhibitor therapy for non-small cell lung cancer. J Manag Care Spec Pharm. 2026 Aug; 32(8):979-993.
-
Pattern of opioid prescriptions among patients with breast, lung, and colorectal cancer diagnosed with pre-existing chronic non-cancer pain. PLoS One. 2026; 21(7):e0352907.
-
Incidence of respiratory syncytial virus in adults =50 years during and following the COVID-19 pandemic in upper midwest USA: a community-based prospective cohort study. BMJ Open. 2026 Jul 21; 16(7):e111773.
-
Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke. J Neurointerv Surg. 2026 Jul 16; 18(8):1749-1756.
-
Relative maternal protection against type 1 diabetes: A combined analysis of 5 observational studies. J Clin Endocrinol Metab. 2026 Jul 15; 111(8):2262-2274.
-
A qualitative study of goals of hospital care and health outcome goals among patients admitted for heart failure. Patient Educ Couns. 2026 Oct; 151:109769.
-
Years of life lost in patients with a false-negative diagnosis of primary melanoma. A prospective study of the German Central Malignant Melanoma Registry involving 9063 patients over 28 years. Nat Commun. 2026 07 02; 17(1).